1. Home
  2. LINC vs MGTX Comparison

LINC vs MGTX Comparison

Compare LINC & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lincoln Educational Services Corporation

LINC

Lincoln Educational Services Corporation

N/A

Current Price

$20.45

Market Cap

813.3M

Sector

Real Estate

ML Signal

N/A

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

N/A

Current Price

$9.47

Market Cap

881.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LINC
MGTX
Founded
1946
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
813.3M
881.7M
IPO Year
2005
2018

Fundamental Metrics

Financial Performance
Metric
LINC
MGTX
Price
$20.45
$9.47
Analyst Decision
Strong Buy
Buy
Analyst Count
5
8
Target Price
★ $47.40
$27.75
AVG Volume (30 Days)
587.9K
★ 737.1K
Earning Date
11-09-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 100.00
33.02
EPS
0.20
★ 1.30
Revenue
★ $261,853,000.00
$81,391,000.00
Revenue This Year
$14.61
$314.19
Revenue Next Year
$9.09
N/A
P/E Ratio
$101.05
★ $7.22
Revenue Growth
32.98
★ 144.57
52 Week Low
$17.29
$6.62
52 Week High
$56.34
$15.35

Technical Indicators

Market Signals
Indicator
LINC
MGTX
Relative Strength Index (RSI) 33.02 37.53
Support Level N/A $8.88
Resistance Level $26.18 $10.11
Average True Range (ATR) 0.94 0.46
MACD -0.02 0.08
Stochastic Oscillator 17.53 27.12

Price Performance

Historical Comparison
LINC
MGTX

About LINC Lincoln Educational Services Corporation

Lincoln Educational Services Corp provides diversified career-oriented post-secondary education to high school graduates and working adults. The company offers programs in automotive technology, skilled trades, healthcare services, hospitality services, and business and information technology. Its reportable segments include: Campus Operations and Transitional. The majority of the revenue is generated from the Campus Operations segment, which includes all campuses that are continuing in operation and contribute to the company's core operations and performance.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

Share on Social Networks: